Metabolomic heterogeneity of pulmonary arterial hypertension
about
Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series)Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in diseaseIntegration of complex data sources to provide biologic insight into pulmonary vascular disease (2015 Grover Conference Series)A Review of Analytical Techniques and Their Application in Disease Diagnosis in Breathomics and Salivaomics ResearchA Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human LungNew Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in HumansSystems medicine: evolution of systems biology from bench to bedsideMetabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioateMetICA: independent component analysis for high-resolution mass-spectrometry based non-targeted metabolomics.Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.Profiling the role of mammalian target of rapamycin in the vascular smooth muscle metabolome in pulmonary arterial hypertension.Pulmonary vascular changes 22 years after single lung transplantation for pulmonary arterial hypertension: a case report with molecular and pathological analysis.(1)H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary HypertensionMetabolic Dysfunction in Pulmonary Arterial Hypertension.Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension.Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosisPlasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.Differentially methylated regions in patients with rheumatic heart disease and secondary pulmonary arterial hypertension.De novo synthesize of bile acids in pulmonary arterial hypertension lung.Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems.Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic studyTowards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans.PPARγ Regulates Mitochondrial Structure and Function and HPASMC Proliferation.Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline.Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathwayMetabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
P2860
Q26772286-F7AB0182-A86A-4AC8-BEE9-61C15D50E62CQ26859449-6F84F2E9-3E97-4ABF-BB8A-A52AADC21FE4Q28069602-FF39EC08-2D22-4C50-A3B1-159DD58D0D3AQ28069683-07F03046-F2F9-4849-B38B-B04BBB073EF8Q28547572-8569172D-C3C0-4B7B-90F5-5094EB899E22Q28553362-C6E49576-4B5A-4468-80FE-2DDE34BDFF41Q35688664-E8BF392E-FF32-4A75-BC53-D471F528BDC0Q35815428-11673096-6034-438E-8112-AC088ECE5C7FQ35943784-A7324AC3-A4BE-4DBB-B7FB-EAE0DFAB3C27Q35944064-A498AC98-8F23-437D-92CB-2D8BE6E57679Q36352098-E9F784FD-2DC4-48E8-8D24-BAE1E6D877B1Q36352139-C26611B9-36CC-4777-AE35-F96645F29B48Q36555906-C651C21B-A93C-453F-A711-EEBC68970E98Q36765972-AEE71072-BA5A-4BF7-A010-F7B208E6F301Q36825335-5316B5A4-59DB-4D7F-B690-6964E00BD72CQ36973719-CF54B177-41CF-42CA-8083-C5DA5FC60A76Q37129851-D1500B99-9866-4B41-B186-624DC5C4084FQ37555371-F2FE2E82-4A89-4EBB-9498-0E3535E57263Q37619276-D8A01804-7BFE-4D3D-A4D7-824E3DBA1B05Q38429846-9AFE8579-971B-4F23-A325-C83D2490F4ABQ38446906-465628CB-B12F-4833-A541-691B9917ED11Q38668387-46308E58-56F9-4864-BEFF-6E5AB8503863Q39317865-A4594477-24B4-4280-B327-7DEA459C4756Q39355985-5D7099A2-3FD2-4D0F-9458-EA639113F081Q41151970-B49CBF49-67E7-49E1-8608-801CB83A4613Q46303809-01F4E0E2-0CF3-495A-97F8-1DE4FFEEEC11Q47356839-06BF838F-2C68-44B1-831D-23E83B7F82AAQ47631019-77974F20-D125-42E1-AA44-EBC137D6B0CCQ49312062-6BD9369E-277D-498D-BEAE-761D162B855BQ55331942-8E35DA58-2D17-4664-B2E2-CCEC5BA13595Q58705752-860550BF-4D93-4702-9048-AE66F7AE2FE3Q58777371-0C13EDC2-D15F-4AE1-81DE-9B06BB82DB32
P2860
Metabolomic heterogeneity of pulmonary arterial hypertension
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolomic heterogeneity of pulmonary arterial hypertension
@ast
Metabolomic heterogeneity of pulmonary arterial hypertension
@en
type
label
Metabolomic heterogeneity of pulmonary arterial hypertension
@ast
Metabolomic heterogeneity of pulmonary arterial hypertension
@en
prefLabel
Metabolomic heterogeneity of pulmonary arterial hypertension
@ast
Metabolomic heterogeneity of pulmonary arterial hypertension
@en
P2093
P2860
P50
P1433
P1476
Metabolomic heterogeneity of pulmonary arterial hypertension
@en
P2093
Catherine Lu
Jenny Peng
John Granton
Marco Mura
Michael Hsin
Ricardo Zamel
Shaf Keshavjee
Thomas Waddell
P2860
P304
P356
10.1371/JOURNAL.PONE.0088727
P407
P577
2014-02-12T00:00:00Z